
Rising Prices of Branded Drugs Pushing Up Popularity of Biosimilars
Biosimilars market is expected to generate $26.7 billion revenue by 2024, advancing at a CAGR of 29.6% during the forecast period, according to P&S Intelligence.
- Pharmaceutical
- Pharmacology
- Biosimilar
- Drug Discovery
Read 367 times